---
cve: "CVE-2026-66875"
severity: "HIGH"
cvss: 8.7
epss: "24%"
vendor: "Quanovate Tech Inc. (operating as Mira / Mira Care)"
kev: false
exploited: false
published: "2026-08-11 22:18:54"
tags: [cve, security, high]
source: tsecurity.de CVE-Dossier
exported: "2026-09-05T12:36:26+02:00"
---

# CVE-2026-66875

> 8.7 HIGH · 🧪 PoC

## Beschreibung

In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.

## CVSS-Vektor

```
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
```

| Metrik | Wert | Bewertung |
|---|---|---|
| AV Angriffsvektor | Benachbart | warn |
| AC Komplexität | Gering | bad |
| PR Privilegien | Keine | bad |
| UI Interaktion | Keine | bad |

## Referenzen

- <https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-01>
- <https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-223-01.json>

---
_Exportiert aus dem [tsecurity.de CVE-Dossier](https://tsecurity.de/cve?cve=CVE-2026-66875) · Datenquellen: EUVD (ENISA), NVD, OSV, CISA KEV, FIRST EPSS, Exploit-DB, BSI BITS_